Literature DB >> 12049479

Inhibition of superoxide dismutase by 2-methoxyoestradiol analogues and oestrogen derivatives: structure-activity relationships.

L Wood1, M R Leese, B Leblond, L W Woo, D Ganeshapillai, A Purohit, M J Reed, B V Potter, G Packham.   

Abstract

Superoxide dismutases catalyse the dismutation of highly reactive superoxide ions to produce hydrogen peroxide and several lines of evidence suggest that these enzymes play important roles in the development and response to treatment of human cancers. For example, Mn-containing superoxide dismutase is frequently overexpressed in various cancer types and can contribute to resistance to apoptosis. 2-Methoxyoestradiol is a naturally occurring metabolic product of 17beta-oestradiol that inhibits tubulin polymerization and possesses growth inhibitory and cytotoxic activity in vitro and in vivo. More recently 2-methoxyoestradiol has also been shown to inhibit superoxide dismutase (SOD) in a tetrazolium salt based enzyme assay, suggesting that oestrogen derivatives might be useful starting points for the development of effective, non-toxic enzyme inhibitors. Here we have tested the SOD inhibiting activity of a range of oestrogen derivatives to determine structural features important for enzyme inhibition.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12049479

Source DB:  PubMed          Journal:  Anticancer Drug Des        ISSN: 0266-9536


  8 in total

Review 1.  Functional genomics of endothelial cells treated with anti-angiogenic or angiopreventive drugs.

Authors:  Adriana Albini; Stefano Indraccolo; Douglas M Noonan; Ulrich Pfeffer
Journal:  Clin Exp Metastasis       Date:  2010-04-10       Impact factor: 5.150

Review 2.  Targeting mitochondria for cancer therapy.

Authors:  Simone Fulda; Lorenzo Galluzzi; Guido Kroemer
Journal:  Nat Rev Drug Discov       Date:  2010-05-14       Impact factor: 84.694

Review 3.  Mitochondrial subversion in cancer.

Authors:  Aditi Chatterjee; Santanu Dasgupta; David Sidransky
Journal:  Cancer Prev Res (Phila)       Date:  2011-05

4.  Novel alterations in superoxide dismutase and catalase activities in the female rabbit bladder subjected to hormonal manipulations.

Authors:  Bulent Onal; Robert M Levin; Barry A Kogan; Ahmet Guven; Robert E Leggett; Anita S Mannikarottu
Journal:  Int Urol Nephrol       Date:  2007-02-28       Impact factor: 2.370

Review 5.  Mitochondrial peroxiredoxin III is a potential target for cancer therapy.

Authors:  In-Sung Song; Hyoung-Kyu Kim; Seung-Hun Jeong; Sung-Ryul Lee; Nari Kim; Byoung Doo Rhee; Kyung Soo Ko; Jin Han
Journal:  Int J Mol Sci       Date:  2011-10-21       Impact factor: 5.923

Review 6.  Mitochondrial Genetic and Epigenetic Regulations in Cancer: Therapeutic Potential.

Authors:  Alexandra Wagner; Helena Kosnacova; Miroslav Chovanec; Dana Jurkovicova
Journal:  Int J Mol Sci       Date:  2022-07-18       Impact factor: 6.208

7.  Mouse models for preeclampsia: disruption of redox-regulated signaling.

Authors:  Subhasis Banerjee; Harpal Randeva; Anne E Chambers
Journal:  Reprod Biol Endocrinol       Date:  2009-01-15       Impact factor: 5.211

Review 8.  Small Molecule Catalysts with Therapeutic Potential.

Authors:  Yannick Ney; Muhammad Jawad Nasim; Ammar Kharma; Lama A Youssef; Claus Jacob
Journal:  Molecules       Date:  2018-03-27       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.